Autologous stem cell therapy in Japan is offered privately by clinics working within a framework that requires treatment plans to be submitted for review before certain regenerative procedures are provided. That process concerns the conduct of treatment rather than confirming that a particular application has been shown to work.
Because the cells come from you, assessment before treatment covers more than the condition itself. General health, age, and current medication may all affect collection and preparation. Ask what assessment is carried out, what would make a clinic decline, and whether that determination happens before or after you have committed to travel.
Ask what happens if processing does not produce the expected result, since this is a practical possibility rather than a theoretical one. Ask what the clinic does in that situation and how it affects the plan and the schedule. A provider that has a clear answer has thought about the process in more depth than one that treats the question as unlikely. Ask as well what costs would apply in that situation, and confirm the answer in writing rather than relying on what was said during consultation.
